2011 Lotus Evora S 2+2 Epson Green Over Slate Grey W/ All The Options on 2040-cars
Bellevue, Washington, United States
Lotus Evora for Sale
- 2013 lotus evora s 2+2 ips, tech pkg, starshield, htd seats, nav, b/t, rear cam!(US $79,500.00)
- Ips new coupe 3.5l cd manual shift mode alloy wheels premium wheels heated seats(US $67,900.00)
- Ips new coupe 3.5l power windows alloy wheels clock trip odometer am/fm stereo(US $68,800.00)
- S new manual coupe 3.5l financing power red spoiler heated seats trip odometer(US $71,800.00)
- 2013 lotus evora ips 2+2 loaded w/low miles(US $68,000.00)
- 2011 lotus evora 2+2 w/2-yr/24,000 mile warranty
Auto Services in Washington
WheelKraft NW ★★★★★
Westside Import Repair ★★★★★
West Coast Auto Glass Inc ★★★★★
Wayne`s Gold Seal Auto Repair ★★★★★
Tomoko Auto Care Ctr ★★★★★
Texaco Xpress Lube ★★★★★
Auto blog
Lotus stepping up to LMP1 in World Endurance Championship
Tue, 18 Feb 2014Only a couple of years ago, it looked like the top tier of prototype endurance racing was in trouble. Peugeot shut down its program, leaving the LMP1 category all to Audi to dominate. Only six cars entered the Petit Le Mans in 2012, and the season was cut short. But the top class in the FIA World Endurance Championship has since blossomed. And it only looks poised to grow further.
Audi and Toyota will each be back on the grid this season, joined by Porsche. But the latest news has Lotus stepping up to the big leagues also. (Well, sorta: the German-run squad uses the Lotus name and colors, but has no more to do with the automaker than the Formula One team of the same name.)
The Lotus LMP1 will be based on the same Lola-based T129 chassis used until now in the LMP2 class, with former F1 driver Christijan Albers leading the driver lineup. In addition to Audi, Toyota and Porsche, the solitary Lotus entry will also compete against privateer Rebellion Racing in a nine-car LMP1 grid throughout the season.
Lotus responds to rumors of demise, promises 2016 MY Evora
Thu, 25 Sep 2014It's not been a great week for Lotus. Seven days ago, the UK-based automaker laid off a quarter of its workforce, terminating "up to 325 jobs." And then, just a few days ago, it was reported that the company would be ending US sales of its well-received Evora due to the expiration of an airbag exemption. The Evora is the only vehicle Lotus sells in the US, meaning its end effectively removes the brand from the market.
That was apparently a bridge too far, though, as the company has issued defiant statement, claiming it'll be back, in both the US and Canada, for model year 2016, with an air-bag compliant Evora.
"I know that this will be welcome news to our thousands of owners and fans in North America, but the reality is that there was never any intention to leave. The North American market is vitally important for us and we intend to expand our dealer network and grow our sales volumes in the future," Jean-Marc Gales, CEO of Group Lotus said in a statement. "I would like to thank our fantastic Lotus following for their support over the years and remind them that we are working on many exciting products for the future. We will continue to explore our core values on how to make a sports car better by making it faster, lighter and maintain the pure driving experience."
Kimi Raikkonen to miss rest of season for back surgery
Sun, 10 Nov 2013Formula One drivers keep themselves in peak physical condition, such are the demands placed on them in order to do what they do. But otherworldly as their capabilities may be, they're still human, and that means they get injured or sick just like the rest of us.
Case in point: Kimi Raikkonen and the announcement made today by Lotus that he'll have to sit out the rest of the season in order to undergo back surgery. That means Lotus will have to find a replacement driver for the last two races in Austin and Brazil while Kimi has and recovers from the operation.
Though we wouldn't debate the legitimacy of Kimi's condition or the necessity to rectify it, the timing is sure to raise some eyebrows. Raikkonen has been at the center of a pay dispute with Lotus, and while the situation was reportedly resolved, his decision to undergo what is said to be elective surgery at this point in the season (as opposed to waiting until its end) raises some questions as to his commitment to the team he is leaving and his team's financial commitments to him in turn.